Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
23.12 USD | +0.43% | -1.15% | +66.09% |
05-16 | Pennant Group Acquires Hospice Provider Nurses on Wheels | MT |
05-16 | The Pennant Group, Inc. acquired Nurses On Wheels, Inc. | CI |
Valuation
Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
---|---|---|---|---|---|---|---|---|
Capitalization 1 | 920.9 | 1,637 | 657.3 | 325.8 | 416.6 | 694.7 | - | - |
Enterprise Value (EV) 1 | 920.9 | 1,637 | 657.3 | 325.8 | 416.6 | 694.7 | 694.7 | 694.7 |
P/E ratio | - | 112 x | 256 x | 49.9 x | 31.6 x | 28.9 x | 24.5 x | 21.5 x |
Yield | - | - | - | - | - | - | - | - |
Capitalization / Revenue | 2.72 x | 4.19 x | 1.49 x | 0.69 x | 0.76 x | 1.1 x | 1.02 x | 0.94 x |
EV / Revenue | 2.72 x | 4.19 x | 1.49 x | 0.69 x | 0.76 x | 1.1 x | 1.02 x | 0.94 x |
EV / EBITDA | 14.8 x | 21.8 x | 9.83 x | 4.8 x | 5.26 x | 7.63 x | 6.9 x | 6.07 x |
EV / FCF | 327 x | - | -26.8 x | -63.6 x | - | 36.6 x | 36.2 x | 27.6 x |
FCF Yield | 0.31% | - | -3.73% | -1.57% | - | 2.74% | 2.76% | 3.63% |
Price to Book | - | - | - | - | - | - | - | - |
Nbr of stocks (in thousands) | 27,847 | 28,190 | 28,477 | 29,677 | 29,927 | 30,046 | - | - |
Reference price 2 | 33.07 | 58.06 | 23.08 | 10.98 | 13.92 | 23.12 | 23.12 | 23.12 |
Announcement Date | 3/4/20 | 2/24/21 | 2/28/22 | 2/23/23 | 2/28/24 | - | - | - |
Income Statement Evolution (Annual data)
Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
---|---|---|---|---|---|---|---|---|
Net sales 1 | 338.5 | 391 | 439.7 | 473.2 | 544.9 | 633.2 | 683.2 | 739.1 |
EBITDA 1 | 62.11 | 75.05 | 66.87 | 67.96 | 79.2 | 91.07 | 100.6 | 114.5 |
EBIT 1 | 23.35 | 31.4 | 62.09 | 63.06 | 35.59 | 47.77 | 53.82 | 53.72 |
Operating Margin | 6.9% | 8.03% | 14.12% | 13.32% | 6.53% | 7.55% | 7.88% | 7.27% |
Earnings before Tax (EBT) | - | - | - | - | 19.58 | - | 42.92 | 47.73 |
Net income 1 | - | 15.74 | 2.696 | 6.643 | 13.38 | 24.36 | 29.23 | 33.7 |
Net margin | - | 4.03% | 0.61% | 1.4% | 2.46% | 3.85% | 4.28% | 4.56% |
EPS 2 | - | 0.5200 | 0.0900 | 0.2200 | 0.4400 | 0.8000 | 0.9450 | 1.075 |
Free Cash Flow 1 | 2.82 | - | -24.53 | -5.126 | - | 19 | 19.2 | 25.2 |
FCF margin | 0.83% | - | -5.58% | -1.08% | - | 3% | 2.81% | 3.41% |
FCF Conversion (EBITDA) | 4.54% | - | - | - | - | 20.86% | 19.08% | 22.01% |
FCF Conversion (Net income) | - | - | - | - | - | 78.01% | 65.69% | 74.77% |
Dividend per Share | - | - | - | - | - | - | - | - |
Announcement Date | 3/4/20 | 2/24/21 | 2/28/22 | 2/23/23 | 2/28/24 | - | - | - |
Income Statement Evolution (Quarterly data)
Fiscal Period: December | 2021 Q4 | 2021 S2 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net sales 1 | 111.8 | 223.7 | 113.9 | 116.3 | 118.4 | 124.7 | 126.5 | 132.3 | 140.2 | 146 | 156.9 | 156.7 | 158.8 | 161.9 | 167.2 | 169.7 |
EBITDA 1 | 15.3 | 32.03 | 15.23 | 16.63 | 16.97 | 19.12 | 17.14 | 19.48 | 20.65 | 21.93 | 21.4 | 22.34 | 23.17 | 24.15 | 24.03 | 25.1 |
EBIT 1 | 14.06 | - | 4.998 | 6.329 | 6.644 | 17.9 | 6.51 | 8.854 | 9.557 | 10.54 | 9.893 | 11.5 | 12.28 | 13.11 | 10.45 | 12.14 |
Operating Margin | 12.58% | - | 4.39% | 5.44% | 5.61% | 14.36% | 5.15% | 6.69% | 6.82% | 7.22% | 6.3% | 7.33% | 7.73% | 8.1% | 6.25% | 7.15% |
Earnings before Tax (EBT) 1 | - | - | - | - | 6.068 | 5.095 | 2.904 | 4.843 | 5.528 | 6.309 | 6.817 | 8.64 | 9.66 | 10.86 | 8.721 | 10.46 |
Net income 1 | -2.149 | - | 1.014 | -2.676 | 4.831 | 3.474 | 1.85 | 2.797 | 4.383 | 4.349 | 4.906 | 5.776 | 6.451 | 7.222 | 6.092 | 6.966 |
Net margin | -1.92% | - | 0.89% | -2.3% | 4.08% | 2.79% | 1.46% | 2.11% | 3.13% | 2.98% | 3.13% | 3.69% | 4.06% | 4.46% | 3.64% | 4.1% |
EPS 2 | -0.0800 | - | 0.0300 | -0.0900 | 0.1600 | 0.1200 | 0.0600 | 0.0900 | 0.1500 | 0.1400 | 0.1600 | 0.1900 | 0.2100 | 0.2350 | 0.2000 | 0.2250 |
Dividend per Share | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Announcement Date | 2/28/22 | 2/28/22 | 5/9/22 | 8/8/22 | 11/7/22 | 2/23/23 | 5/4/23 | 8/8/23 | 11/7/23 | 2/28/24 | 5/6/24 | - | - | - | - | - |
Balance Sheet Analysis
Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
---|---|---|---|---|---|---|---|---|
Net Debt | - | - | - | - | - | - | - | - |
Net Cash position | - | - | - | - | - | - | - | - |
Leverage (Debt/EBITDA) | - | - | - | - | - | - | - | - |
Free Cash Flow 1 | 2.82 | - | -24.5 | -5.13 | - | 19 | 19.2 | 25.2 |
ROE (net income / shareholders' equity) | - | - | - | - | - | 16.5% | - | - |
ROA (Net income/ Total Assets) | - | - | - | - | - | - | - | - |
Assets 1 | - | - | - | - | - | - | - | - |
Book Value Per Share | - | - | - | - | - | - | - | - |
Cash Flow per Share | - | - | -0.5900 | 0.3000 | - | - | - | - |
Capex | 6.73 | - | 6.3 | 14.2 | - | - | - | - |
Capex / Sales | 1.99% | - | 1.43% | 2.99% | - | - | - | - |
Announcement Date | 3/4/20 | 2/24/21 | 2/28/22 | 2/23/23 | 2/28/24 | - | - | - |
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+66.09% | 692M | |
+1.13% | 3.09B | |
0.00% | 1.97B | |
+19.18% | 1.79B | |
-13.53% | 414M | |
-45.62% | 313M | |
-21.08% | 170M | |
-14.94% | 135M | |
+1.92% | 67.94M |
- Stock Market
- Equities
- PNTG Stock
- Financials The Pennant Group, Inc.